RA Capital Management as of June 30, 2011
Portfolio Holdings for RA Capital Management
RA Capital Management holds 23 positions in its portfolio as reported in the June 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| OncoGenex Pharmaceuticals | 8.9 | $9.0M | 528k | 17.03 | |
| Columbia Laboratories | 8.9 | $8.9M | 2.9M | 3.09 | |
| ACADIA Pharmaceuticals (ACAD) | 8.5 | $8.6M | 5.3M | 1.63 | |
| Inhibitex | 8.4 | $8.5M | 2.2M | 3.92 | |
| Alexza Pharmaceuticals | 7.1 | $7.1M | 3.9M | 1.82 | |
| ADVENTRX Pharmaceuticals | 7.1 | $7.1M | 2.4M | 3.01 | |
| Derma Sciences | 7.1 | $7.1M | 772k | 9.21 | |
| Pharmasset | 5.6 | $5.6M | 50k | 112.20 | |
| Affymax (AFFY) | 4.2 | $4.2M | 617k | 6.87 | |
| Furiex Pharmaceuticals | 3.9 | $3.9M | 221k | 17.79 | |
| Arthrocare Corp | 3.6 | $3.6M | 407k | 8.90 | |
| Enzo Biochem (ENZ) | 3.6 | $3.6M | 844k | 4.25 | |
| Anacor Pharmaceuticals In | 3.4 | $3.5M | 535k | 6.46 | |
| BioSpecifics Technologies | 3.3 | $3.4M | 150k | 22.40 | |
| Aegerion Pharmaceuticals | 3.1 | $3.2M | 200k | 15.75 | |
| GTx | 3.0 | $3.0M | 625k | 4.79 | |
| Gentium S.p.A. | 2.3 | $2.3M | 238k | 9.89 | |
| ImmunoGen | 2.3 | $2.3M | 188k | 12.19 | |
| Dynavax Technologies Corporation | 1.5 | $1.5M | 564k | 2.75 | |
| AVEO Pharmaceuticals | 1.5 | $1.5M | 75k | 20.61 | |
| RTI Biologics | 1.4 | $1.4M | 504k | 2.71 | |
| Nabi Biopharmaceuticals | 1.0 | $961k | 179k | 5.38 | |
| Discovery Laboratories | 0.2 | $253k | 113k | 2.25 |
